Update on HIPAA Administration and Enforcement

Valerie Montoya Equal Opportunity Specialist – Investigator OCR - DHHS/OS

• Understand what uses/disclosures of PHI are permitted during the pandemic
• Identify breach trends
• Implement best practices for your compliance program

Presentation
Evaluation

Demystifying Drug Diversion: A Compliance Professional’s Perspective

Alex Raymond, PharmD, MS, CHC Director – Drug Diversion Ochsner Health

• Define Healthcare related Drug Diversion
• Associate the Seven Basic Compliance Program Elements to Drug Diversion Prevention and Response Program
• Define Technologies and Future Goals for Proactive Drug Diversion Monitoring
• Apply Methods for Proactive Drug Diversion Monitoring
• Discuss Drug Diversion Pitfalls During a National Pandemic

Presentation
Evaluation

COVID-19 Related Compliance Risks and Associated Audit Plan Considerations

Ryan Haggerty Consulting Principal RSM US LLP

• Understand the connection between COVID-19 related topics and associated regulatory compliance risk(s)
• Leverage basic analytics and apply risk assessment feedback to inform the prioritization and selection of COVID-19 related audit areas
• Learn how to approach the design and completion of the COVID-19 related compliance audits selected for your plan
 

Presentation
Evaluation

The Basics of EMTALA and Beyond

Kathy L. Poppitt Partner King & Spalding

• Understand the basics of EMTALA requirements and how they apply, or don’t, to your facility
• Define the stated EMTALA requirements and how to meet them
• Apply the EMTALA requirements to specific scenarios
• Recognize when EMTALA does not apply
• Understand how the new federal No Surprise Billing Law may affect EMTATL requirements

Presentation
Evaluation

HIPAA Breach: What Do I Do Now

Lanzi Meyers, J.D. Attorney Gachassin Law Firm

• A walk-through of how to determine if a HIPAA breach has occurred
• Guidance on investigating and conducting a risk assessment
• Guidance on required notifications

Presentation
Evaluation

The Federal Government’s Approach to Healthcare Compliance

Davis Rhorer, Jr. Assistant United States Attorney Middle District of Louisiana
Chase E. Zachary Assistant United States Attorney Middle District of Louisiana

• Understand the United States’ criminal, civil, and administrative enforcement tools to combat health care fraud and drug diversion
• Identify common and emerging areas of health care fraud
• Assess the effectiveness of compliance programs based on the Department of Justice’s “Evaluation of Corporate Compliance Programs” guidelines

No Presentation Available
Evaluation